CRP and hepatocellular carcinoma: BMI has been shown to be an important confounder for CRP (Liu et al., 2017, McDade et al., 2016, Dowd et al., 2010) and HCC (Rippe et al., 2016, Stalder et al., 2017), but is unrelated to EBV (McClure et al., 2010).